References
- Gebhardt, R., Hengstler, J.G., Müller, D., Glöckner, R., Buenning, P., Laube, B.,et al. (2003). New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab Rev 35:145–213.
- Hengstler, J.G., Van der Burg, B., Steinberg, P., Oesch, F. (1999). Interspecies differences in cancer susceptibility and toxicity. Drug Metab Rev 31:917–970.
- Hengstler, J.G., Utesch, D., Steinberg, P., Platt, K.L., Diener, B., Ringel, M., et al. (2000). Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev 32:81–118.
- Hewitt, N.J., Lecluyse, E.L., Ferguson, S.S. (2007). Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro–in vivo correlations. Xenobiotica 37:1196–1224.
- Oesch, F., Oesch-Bartlomowicz, B., Arens, J., Fähndrich, F., Vogel, E., Friedberg, T., et al. (1994). Mechanism-based predictions of interactions. Environ Health Perspect 102(Suppl 9):5–9.
- Oesch-Bartlomowicz, B., Richter, B., Becker, R., Vogel, S., Padma, P.R., Hengstler, J.G., et al. (2001). cAMP-dependent phosphorylation of CYP2B1 as a functional switch for cyclophosphamide activation and its hormonal control in vitro and in vitro. Int J Cancer 94:733–742.
- Paakkari, I. (2002). Cardiotoxicity of new antihistamines and cisapride. Toxicol Lett 127:279–284.
- Reder-Hilz, B., Ullrich, M., Ringel, M., Hewitt, N., Utesch, D., Oesch, F., et al. (2004). Metabolism of propafenone and verapamil by cryopreserved human, rat, mouse, and dog hepatocytes: comparison with metabolism in vitro. Naunyn Schmiedebergs Arch Pharmacol 369:408–417.
- Strolin Benedetti, M., Plisnier, M., Whomsley, R., Espié, P., Canning, M. (2007). A metabolic pathway of levocetirizine important in the rat and absent in the dog and humans. Drug Metab Rev 39(Suppl 1):361.
- Wijnen, P.A., Op den Buijsch, RA, Drent, M., Kuipers, P.M., Neef, C., Bast, A., et al. (2007). The prevalence and clinical relevance of cytochrome P450 polymorphisms. Aliment Pharmacol Ther 2:211–219.